Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

ETANERCEPT

  • You have access
    When to Adjust Therapy in Patients with Rheumatoid Arthritis After Initiation of Etanercept plus Methotrexate or Methotrexate Alone: Findings from a Randomized Study (COMET)
    Maxime R. Dougados, Désirée M. van der Heijde, Yves Brault, Andrew S. Koenig and Isabelle S. Logeart
    The Journal of Rheumatology October 1 2014, 41 (10) 1922-1934; DOI: https://doi.org/10.3899/jrheum.131238
  • Open Access
    Persistence and Dose Escalation of Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Grant W. Cannon, Scott L. DuVall, Candace L. Haroldsen, Liron Caplan, Jeffrey R. Curtis, Kaleb Michaud, Ted R. Mikuls, Andreas Reimold, David H. Collier, David J. Harrison, George J. Joseph and Brian C. Sauer
    The Journal of Rheumatology October 1 2014, 41 (10) 1935-1943; DOI: https://doi.org/10.3899/jrheum.140164
  • You have access
    Consistently Good Clinical Response in Patients with Early Axial Spondyloarthritis After 3 Years of Continuous Treatment with Etanercept: Longterm Data of the ESTHER Trial
    In-Ho Song, Kay-Geert Hermann, Hildrun Haibel, Christian E. Althoff, Denis Poddubnyy, Joachim Listing, Anja Weiß, Beate Buß, Bruce Freundlich, Ekkehard Lange, Rieke Alten, Martin Rudwaleit and Joachim Sieper
    The Journal of Rheumatology October 1 2014, 41 (10) 2034-2040; DOI: https://doi.org/10.3899/jrheum.140056
  • You have access
    Longterm Retention Rate and Risk Factor for Discontinuation Due to Insufficient Efficacy and Adverse Events in Japanese Patients with Rheumatoid Arthritis Receiving Etanercept Therapy
    Hiroyuki Matsubara, Toshihisa Kojima, Atsushi Kaneko, Yuji Hirano, Hisato Ishikawa, Yousuke Hattori, Hiroyuki Miyake, Takeshi Oguchi, Hideki Takagi, Yuichiro Yabe, Takefumi Kato, Takayasu Ito, Naoki Fukaya, Yasuhide Kanayama, Tomone Shioura, Masatoshi Hayashi, Takayoshi Fujibayashi, Nobunori Takahashi, Koji Funahashi, Daizo Kato, Masahiro Hanabayashi, Kenya Terabe and Naoki Ishiguro
    The Journal of Rheumatology August 1 2014, 41 (8) 1583-1589; DOI: https://doi.org/10.3899/jrheum.130901
  • You have access
    Adalimumab, Etanercept, Infliximab, and the Risk of Tuberculosis: Data from Clinical Trials, National Registries, and Postmarketing Surveillance
    Fabrizio Cantini, Laura Niccoli and Delia Goletti
    The Journal of Rheumatology Supplement May 1 2014, 91 47-55; DOI: https://doi.org/10.3899/jrheum.140102
  • You have access
    Safety and Effectiveness of 6 Months’ Etanercept Monotherapy and Combination Therapy in Japanese Patients with Rheumatoid Arthritis: Effect of Concomitant Disease-modifying Antirheumatic Drugs
    Takao Koike, Masayoshi Harigai, Shigeko Inokuma, Naoki Ishiguro, Junnosuke Ryu, Tsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, Tomohiro Hirose, Takunari Yoshinaga and Michio Suzukawa
    The Journal of Rheumatology October 1 2013, 40 (10) 1658-1668; DOI: https://doi.org/10.3899/jrheum.120490
  • You have access
    Etanercept Improves Lipid Profile and Oxidative Stress Measures in Patients with Juvenile Idiopathic Arthritis
    Sara De Sanctis, M. Loredana Marcovecchio, Stefania Gaspari, Marianna Del Torto, Angelika Mohn, Francesco Chiarelli and Luciana Breda
    The Journal of Rheumatology June 1 2013, 40 (6) 943-948; DOI: https://doi.org/10.3899/jrheum.121281
  • You have access
    Clinical Response Within 12 Weeks as a Predictor of Future Low Disease Activity in Patients with Early RA: Results from the TEAR Trial
    Jeffrey R. Curtis, Theresa McVie, Ted R. Mikuls, Richard J. Reynolds, Iris Navarro-Millán, James O’Dell, Larry W. Moreland, S. Louis Bridges Jr., Veena K. Ranganath and Stacey S. Cofield
    The Journal of Rheumatology May 1 2013, 40 (5) 572-578; DOI: https://doi.org/10.3899/jrheum.120715
  • You have access
    Factors Associated with Achievement of Inactive Disease in Children with Juvenile Idiopathic Arthritis Treated with Etanercept
    NICOLETTA SOLARI, ELENA PALMISANI, ALESSANDRO CONSOLARO, ANGELA PISTORIO, STEFANIA VIOLA, ANTONELLA BUONCOMPAGNI, MARCO GATTORNO, PAOLO PICCO, NICOLINO RUPERTO, CLARA MALATTIA, ALBERTO MARTINI and ANGELO RAVELLI
    The Journal of Rheumatology February 1 2013, 40 (2) 192-200; DOI: https://doi.org/10.3899/jrheum.120842

Pages

  • Previous
  • 1
  • 2
  • 3

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire